178 related articles for article (PubMed ID: 37328455)
1. Cancer genomes tolerate deleterious coding mutations through somatic copy number amplifications of wild-type regions.
Alfieri F; Caravagna G; Schaefer MH
Nat Commun; 2023 Jun; 14(1):3594. PubMed ID: 37328455
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
3. Author Correction: Cancer genomes tolerate deleterious coding mutations through somatic copy number amplifications of wild-type regions.
Alfieri F; Caravagna G; Schaefer MH
Nat Commun; 2023 Jul; 14(1):4423. PubMed ID: 37479721
[No Abstract] [Full Text] [Related]
4. Mutation discovery in regions of segmental cancer genome amplifications with CoNAn-SNV: a mixture model for next generation sequencing of tumors.
Crisan A; Goya R; Ha G; Ding J; Prentice LM; Oloumi A; Senz J; Zeng T; Tse K; Delaney A; Marra MA; Huntsman DG; Hirst M; Aparicio S; Shah S
PLoS One; 2012; 7(8):e41551. PubMed ID: 22916110
[TBL] [Abstract][Full Text] [Related]
5. Characterization of TERT and BRAF copy number variation in papillary thyroid carcinoma: An analysis of the cancer genome atlas study.
McKelvey BA; Zeiger MA; Umbricht CB
Genes Chromosomes Cancer; 2021 Jun; 60(6):403-409. PubMed ID: 33305870
[TBL] [Abstract][Full Text] [Related]
6. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
Koboldt DC; Zhang Q; Larson DE; Shen D; McLellan MD; Lin L; Miller CA; Mardis ER; Ding L; Wilson RK
Genome Res; 2012 Mar; 22(3):568-76. PubMed ID: 22300766
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel.
Shen C; Meric-Bernstam F; Su X; Mendelsohn J; Giordano S
Oncotarget; 2016 Nov; 7(44):71686-71695. PubMed ID: 27634896
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer patterns of somatic copy number alteration.
Zack TI; Schumacher SE; Carter SL; Cherniack AD; Saksena G; Tabak B; Lawrence MS; Zhsng CZ; Wala J; Mermel CH; Sougnez C; Gabriel SB; Hernandez B; Shen H; Laird PW; Getz G; Meyerson M; Beroukhim R
Nat Genet; 2013 Oct; 45(10):1134-40. PubMed ID: 24071852
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains.
Berg KCG; Sveen A; Høland M; Alagaratnam S; Berg M; Danielsen SA; Nesbakken A; Søreide K; Lothe RA
Oncogene; 2019 Aug; 38(33):6109-6122. PubMed ID: 31308487
[TBL] [Abstract][Full Text] [Related]
10. Somatic amplifications and deletions in genome of papillary thyroid carcinomas.
Passon N; Bregant E; Sponziello M; Dima M; Rosignolo F; Durante C; Celano M; Russo D; Filetti S; Damante G
Endocrine; 2015 Nov; 50(2):453-64. PubMed ID: 25863487
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
[TBL] [Abstract][Full Text] [Related]
12. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
13. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
[TBL] [Abstract][Full Text] [Related]
14. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
15. Domain landscapes of somatic mutations in cancer.
Nehrt NL; Peterson TA; Park D; Kann MG
BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S9. PubMed ID: 22759657
[TBL] [Abstract][Full Text] [Related]
16. A systematic comparison of copy number alterations in four types of female cancer.
Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
[TBL] [Abstract][Full Text] [Related]
17. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
18. Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants.
Nawrocka PM; Galka-Marciniak P; Urbanek-Trzeciak MO; M-Thirusenthilarasan I; Szostak N; Philips A; Susok L; Sand M; Kozlowski P
Front Oncol; 2021; 11():752579. PubMed ID: 34900699
[TBL] [Abstract][Full Text] [Related]
19. Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic cases.
Pfarr N; Penzel R; Klauschen F; Heim D; Brandt R; Kazdal D; Jesinghaus M; Herpel E; Schirmacher P; Warth A; Weichert W; Endris V; Stenzinger A
Genes Chromosomes Cancer; 2016 Nov; 55(11):821-33. PubMed ID: 27218826
[TBL] [Abstract][Full Text] [Related]
20. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
